ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

DCPC Board Okays Core Grant Changes On Shared Resources

January 30, 1987

In Brief: Fredrickson Okays NCI Reorganization, Plan At Hew; Miller Leave International Affairs Job

February 8, 1980

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

Niederhuber To Stay at NCI While Obama Makes NIH Plans

January 23, 2009

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995